NGX6 expression improves the sensitivity of tamoxifen-resistant MCF-7 cells through modulation of the Smad signaling pathway

International Journal of Oncology

Volumn 42, Issue 6, 2013, Pages 2060-2068

  Zhao, Wen Jing ^a   Wang, Ke ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer; NGX6; Smad2 3; Tamoxifen

Indexed keywords

NASOPHARYNGEAL CARCINOMA ASSOCIATED GENE 6; PEPTIDES AND PROTEINS; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMALL INTERFERING RNA; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MODULATION; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RNA INTERFERENCE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; THREE DIMENSIONAL IMAGING;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MCF-7 CELLS; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR DOCKING SIMULATION; PROTEIN CONFORMATION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TAMOXIFEN; TUMOR SUPPRESSOR PROTEINS;

EID: 84876584976     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1886     Document Type: Article

References (34)

1. Zainuddin N, Jaafart H, Isa MN, et al: Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma. Neurol Res 26: 88-92, 2004. (Pubitemid 38174394)
2. Nishisaka T, Takeshima Y and Inai K: Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precan-cerous lesions of 29 lung cancer patients. Hiroshima J Med Sci 49: 109-116, 2000.
3. Wistuba II, Behrens C, Milchgrub S, et al: Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 18: 643-650, 1999. (Pubitemid 29080321)
4. Perinchery G, Bukurov N, Nakajima K, et al: High frequency of deletion on chromosome 9p21 may harbor several tumor-suppressor genes in human prostate cancer. Int J Cancer 83: 610-614, 1999. (Pubitemid 29508038)
5. Partridge M, Emilion G, Pateromichelakis S, et al: Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 83: 318-325, 1999. (Pubitemid 29455754)
6. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002. (Pubitemid 35403967)
7. Peng S, Fan S, Li X, et al: The expression of ezrin in NPC and its interaction with NGX6, a novel candidate suppressor. Cancer Sci 8: 341-349, 2007. (Pubitemid 46195604)
8. Ma J, Zhou J, Fan S, et al: Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis 26: 281-291, 2005. (Pubitemid 40246549)
9. Wang L, Ma J, Li J, et al: NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem 95: 64-73, 2005. (Pubitemid 41420216)
10. Jemal A, Bray F, Center MM, et al: Global cancer statistics. CA Cancer J Clin 6: 69-90, 2011.
11. Xiong J, Yu D, Wei N, et al: An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples. FEBS J 277: 1684-1694, 2010.
12. Hu Y, Fan L, Zheng J, et al: Detection of circulating tumor cells in breast cancer patients utilizing multiparameter fow cytometry and assessment of the prognosis of patients in different CTCs levels. Cytometry A 77: 213-219, 2010.
13. Zhou F F, Xia LP, Wang X, et al: Analysis of prognostic factors in male breast cancer: a report of 72 cases from a single institution. Chin J Cancer 29: 184-188, 2010.
14. Arpino G, De Angelis C, Giuliano M, et al: Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer. Oncology 77 (Suppl 1): 23-37, 2009.
15. Henry NL and Hayes DF: Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy? J Clin Oncol 25: 2501-2503, 2007. (Pubitemid 47041219)
16. Jaiyesimi IA, Buzdar AU, Decker DA, et al: Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 13: 513-529, 1995.
17. Kim MR, Choi HK, Cho KB, et al: Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells. Cancer Sci 100: 1834-1841, 2009.
18. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
19. Markaryan A, Nelson EG, Tretiakova M, et al: Technical report: immunofuorescence and TUNEL staining of celloidin embedded human temporal bone tissues. Hear Res 241: 1-6, 2008.
20. Hurst PR, Mora JM and Fenwick MA: Caspase-3, TUNEL and ultrastructural studies of small follicles in adult human ovarian biopsies. Hum Reprod 21: 1974-1980, 2006. (Pubitemid 44288069)
21. Bennett-Lovsey RM, Herbert AD, Sternberg MJ, et al: Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre. Proteins 70: 611-625, 2008. (Pubitemid 351161924)
22. Kelley LA and Sternberg MJ: Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 4: 363-371, 2009.
23. Martí-Renom MA, Stuart AC, Fiser A, et al: Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 29: 291-325, 2000. (Pubitemid 30599596)
24. Szklarczyk D, Franceschini A, Kuhn M, et al: The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39 (Database issue): D561-D568, 2011.
25. D'Arcangelo G, Miao GG, Chen SC, et al: A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374: 719-723, 1995.
26. Wang L, Xiang B, Yi M, et al: Identifcation of a new seven-span transmembrane protein: NGX6a is downregulated in nasopha-ryngeal carcinoma and is associated with tumor metastasis. J Histochem Cytochem 58: 41-51, 2010.
27. Guo Q, Shen S, Liao M, et al: NGX6 inhibits cell invasion and adhesion through suppression of Wnt/betacatenin signal pathway in colon cancer. Acta Biochim Biophys Sin 42: 450-456, 2010.
28. Xiao JD and Shen SR: Expression and signifcance of NGX6 gene in human hepatocellular carcinoma. Zhong Nan Da Xue Xue Bao Yi Xue Ban 33: 937-941, 2008.
29. Eskandari-Nasab E, Hashemi M, Rezaei H, et al: Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofo-late reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer. Mol Biol Rep 39: 10531-10539, 2012.
30. Wang XY, Wu MH, Liu F, et al: Differential miRNA expression and their target genes between NGX6-positive and negative colon cancer cells. Mol Cell Biochem 345: 283-290, 2010.
31. Guo Q, Wu M, Lian P, et al: Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway. Mol Cell Biochem 330: 71-81, 2009.
32. Peng Y, Li H, Wu M, et al: NGX6 inhibits AP-1 and Ets-1 expression and down-regulates cyclin D1 in human colorectal cancer. Acta Biochim Biophys Sin 41: 504-514, 2009.
33. Schmierer B and Hill CS: TGFbeta-SMAD signal transduction: molecular specifcity and functional fexibility. Nat Rev Mol Cell Biol 8: 970-982, 2007. (Pubitemid 350174642)
34. Jacob D, Davis J, Zhu H, et al: Suppressing orthotopic pancreatic tumor growth with a fber-modifed adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Clin Cancer Res 10: 3535-3541, 2004. (Pubitemid 38685464)